SLCO1B1 and myopathy: A statistically significant association between SLCO1B1 gene T521C polymorphism and statin-related myopathy risk was found (TC + CC vs TT: OR = 2.09, 95% CI = 1.27–3.43, P = 0.003; C vs T: OR = 2.10, 95% CI = 1.43–3.09, P < 0.001), indicating that the allele C carriers may be more intolerant to satins.